FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/05/2021 |
3. Issuer Name and Ticker or Trading Symbol
SYNCHRONOSS TECHNOLOGIES INC [ SNCR ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 44,047(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (Right to Buy) | 06/06/2020 | 06/06/2026 | Common Stock(2) | 8,283 | 6.88 | D | |
Stock Option (Right to Buy) | 02/20/2021 | 02/20/2026 | Common Stock(3) | 20,718 | 5.43 | D | |
Stock Option (Right to Buy) | 09/11/2022 | 09/11/2027 | Common Stock(4) | 25,000 | 3.74 | D | |
Stock Option (Right to Buy) | 06/14/2022 | 06/14/2028 | Common Stock(5) | 29,730 | 2.94 | D |
Explanation of Responses: |
1. Shares of restricted stock granted pursuant to the Company's 2015 Equity Incentive Plan. 937 shares vest on each of November 1, 2021 and February 1, 2022; 3,520 shares vest on June 6, 2022; 9,910 shares vest on each of June 14, 2022, April 9, 2023 and April 9, 2024. |
2. The option shall become exerciseable with respect to one-third of the shares subject to the option when the Reporting Person completes continuous service on each of June 6, 2020, March 6, 2021 and March 6, 2022. |
3. The option shall become exerciseable with respect to one-third of the shares subject to the option when the Reporting Person completes each year of continuous service on each of February 20, 2020, 2021 and 2022. |
4. The option shall become exerciseable when the Reporting Person completes continuous service on September 11, 2022. |
5. The option shall become exerciseable with respect to one-third of the shares subject to the option, on each of June 14, 2022, April 9, 2023 and April 9, 2024, provided the Reporting Person completes continuous service. |
Remarks: |
Lou Ferraro | 08/12/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |